✦ LIBER ✦

6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

✍ Scribed by Maraveyas, A.; Waters, J.; Roy, R.; Propper, D.; Fyfe, D.; Lofts, F.; Gardiner, E.; Sgouros, J.; Wedgwood, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OC-02 Gemcitabine with or without prophy

✍ A. Maraveyas; J. Waters; R. Roy; D. Propper; D. Fyfe; F. Lofts; G. Bozas; E. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Gemcitabine alone or in combination with

✍ Valle, J W; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; Baka, S; Mara 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB

Gemcitabine and capecitabine with or wit

✍ Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Pr 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB